DexCom Inc
USUSDDexCom Inc (US:DXCM) — Medical Devices. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 4. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par uzņēmumu
- Tīmekļvietne
- dexcom.com
- Nozare
- Healthcare · Medical Devices
- Galvenā mītne
- SAN DIEGO, United States
- Izpilddirektors
- Jacob Steven Leach
- Darbinieki
- 11 000
- Dibināts
- 1999
- Apgrozībā esošās akcijas
- 377.36 milj. uz 2026-07-23
- Brīvā apgrozība
- 375.99 milj.
- Tirgus kapitalizācija
- 32.69 mljrd. USD
- Iekšējās personas
- 0.26%
- Institucionālie investori
- 106.4%
- Nozare (SIC)
- Surgical & Medical Instruments & Apparatus
- Juridiskā forma
- XTIQ
- ISIN
- US2521311074
- LEI
- 549300YSK3QDSFR5EU59
- FCF
- 1.41 mljrd. USD
- Parāds
- 0 USDneto nauda
- Peļņa un FCF — par 12 mēnešiem līdz 30.06.2026 (uzņēmuma jaunākais ziņojums).
Apraksts
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Ziņas šonedēļ
Preses relīzes no uzņēmuma investoru mājaslapas, kas tiek atjauninātas katru dienu. Saites ved uz uzņēmuma mājaslapu. Virsraksti ir oriģinālvalodā, kā uzņēmuma mājaslapā.
Lielākie akcionāri
| Turētājs | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| Blackrock Inc. | 10.13% | 38.24 milj. | 2026-06-30 |
| Vanguard Capital Managem… | 6.68% | 25.21 milj. | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.21% | 19.66 milj. | 2026-06-30 |
| State Street Corporation | 4.87% | 18.38 milj. | 2026-06-30 |
| Invesco Ltd. | 4.05% | 15.29 milj. | 2026-06-30 |
| BAILLIE GIFFORD & CO | 3.92% | 14.8 milj. | 2026-06-30 |
| Geode Capital Management… | 3.29% | 12.43 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.25% | 12.25 milj. | 2026-06-30 |
| Alliancebernstein L.P. | 3.1% | 11.69 milj. | 2026-06-30 |
| UBS AM, a distinct busin… | 2.98% | 11.26 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.65% | 10 milj. | 2026-06-30 |
| Wellington Management Gr… | 2.26% | 8.53 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.22% | 8.36 milj. | 2026-06-30 |
| Invesco QQQ Trust, Serie… | 2.2% | 8.3 milj. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 1.69% | 6.37 milj. | 2026-04-30 |
| iShares Trust-iShares Co… | 1.38% | 5.21 milj. | 2026-07-31 |
| Fidelity Concord Street… | 1.32% | 4.99 milj. | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.31% | 4.95 milj. | 2026-06-30 |
| SPDR S&P 500 ETF TRUST-S… | 1.25% | 4.71 milj. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.78% | 2.96 milj. | 2026-06-30 |
| LEACH JACOB STEVEN (Chie… | ≈0.12% | 469 106 | 2026-03-06 |
| TOPOL ERIC J (Director) | ≈0.1% | 380 545 | 2025-05-08 |
| SAYER KEVIN R (Officer a… | ≈0.08% | 302 214 | 2026-08-20 |
| SYLVAIN JEREME M (Chief… | ≈0.04% | 146 828 | 2026-09-10 |
| STERN SADIE (Officer) | ≈0.03% | 126 043 | 2026-08-27 |
| BROWN MICHAEL JON (Offic… | ≈0.03% | 99 885 | 2026-09-15 |
| COLEMAN JON (Officer) | ≈0.03% | 95 450 | 2026-06-04 |
| ALTMAN STEVEN R (Directo… | ≈0.02% | 69 232 | 2026-05-28 |
| COLLINS RICHARD ALEXANDE… | ≈0.01% | 45 767 | 2026-05-28 |
| FOLETTA MARK G (Director… | — | — | 2026-08-03 |